← Leaderboards
Kevin W. Freeman
University Of Tennessee Health Sci Ctr
$2,091,221
Attributed
$2,450,277
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $718.1K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,450,277 · 2
By mechanism
R01$2,450,277 · 2
Top collaborators
- Jun Yang1 shared
Most similar at University Of Tennessee Health Sci Ctr
Same institution · by research overlap
- Yi Zheng$32,153,231
- Sarah M Neuner$368,731
Others in their field
Other Emerging Leaders on “Response”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$195,683,539
- Kimberly Smith · Ppd Development Lp$115,671,664
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
Research focus
ResponseTumorigenesisNovel TherapeuticsResistanceSympathetic Nervous SystemTumorMalignant NeoplasmsNeuroblastoma CellOverexpressionRecurrent DiseaseEpigenetic ProcessGeneticGenetic TranscriptionTranscription FactorEnhancersMalignant Childhood NeoplasmMutationNeuroblastomaHistonesCessation Of LifeHigh RiskPathway InteractionsBindingCancer Cell Line
Grant awards (6)
Targetable epigenetic modifiers that promote neuroblastoma malignancy and plasticity$718,113
R01 · FY2025 · CA
Dissecting the contribution of the transcriptional regulators of SNS fate to neuroblastoma oncogenesis$340,746
R01 · FY2022 · CA · contact PI
Dissecting the contribution of the transcriptional regulators of SNS fate to neuroblastoma oncogenesis$347,700
R01 · FY2021 · CA · contact PI
Dissecting the contribution of the transcriptional regulators of SNS fate to neuroblastoma oncogenesis$358,750
R01 · FY2020 · CA · contact PI
Dissecting the contribution of the transcriptional regulators of SNS fate to neuroblastoma oncogenesis$337,268
R01 · FY2019 · CA · contact PI
Dissecting the contribution of the transcriptional regulators of SNS fate to neuroblastoma oncogenesis$347,700
R01 · FY2018 · CA · contact PI